The discovery of novel antibiotics which have unique targets to inhibit the growth of microorganisms will minimize the suffering of those who are desperately in need of alternatives to currently available antibiotics. The competition for resources by microorganisms has led to their ability to make a wide variety of natural products that can inhibit the growth of their competitors. These antimicrobial compounds provide the best opportunity to alleviate the pain and suffering caused by infectious diseases. My research program encompasses the isolation, identification, and the development of novel antimicrobials as therapeutics. A biotechnology company named Sano Chemicals was established to promote the commercialization of technology generated from my research laboratory at Texas A&M University.